IGF1 and Parkinson disease: As follows, there is a certain association between IGF-1 and estrogens and their protective effects exerted in nigrostriatal dopamine neurons after 6-hydroxdopamine lesions; suggesting them as an useful therapy to palliate PD symptoms [37].